Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1945–1968 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Peripheral Neuropathy
Interventions: Not listed
Lead sponsor: Power Life Sciences Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Type 1 Diabetes
Interventions: Tandem Automated Insulin Delivery System; Device
Lead sponsor: Stanford University; Other
Eligibility: 2 Years to 26 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Hand Injury Rehabilitation, Postoperative Rehabilitation
Interventions: AI-Based Camera Tele-Rehabilitation Monitoring System, Standard Telehealth Rehabilitation; Device · Behavioral
Lead sponsor: Mississippi State University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Jackson, Mississippi • Starkville, Mississippi

Conditions: Depression / Major Depressive Disorder
Interventions: Augmented Depression Therapy (ADepT); Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hepatocellular Carcinoma, Liver Cancer
Interventions: Durvalumab, Zanzalintinib; Drug
Lead sponsor: Amit Mahipal; Other
Eligibility: 19 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Obesity
Interventions: Weight loss intervention, No Weight loss intervention; Behavioral
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 5 Years to 12 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2036
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Intellectual Disabilities, Developmental Disability
Interventions: Comprehensive Community Health, Regular Special Olympics programming; Behavioral · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 21 Years to 65 Years
Enrollment: 1,040 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: PTSD
Interventions: Treatment As Usual, New Health Services Intervention; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pancreatitis, Pancreatitis, Acute, Pancreatitis, Chronic, Pancreas Disease, Acute Recurrent Pancreatitis
Interventions: Intermittent Fasting, No intermittent fasting; Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Epilepsy
Interventions: Brain Interchange System; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 3 Years to 70 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Rochester, Minnesota • Houston, Texas

Conditions: Tobacco Use Disorder/Cigarette Smoking, HIV
Interventions: nicotine patch, nicotine gum, nicotine lozenge, varenicline, bupropion, Multi-target Contingency Management, Teamlet booster; Drug · Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 794 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 5
States / cities: Bridgeport, Connecticut • New Haven, Connecticut • Jersey City, New Jersey + 2 more

Conditions: Healthy Volunteers, Malaria, Plasmodium Vivax
Interventions: Plasmodium vivax Challenge Agent Derived from PvHMB-CCE001, Pvs230D1-EPA/Matrix-M; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 54 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hernia, Hiatal, Pneumoperitoneum, Postoperative Pain, Shoulder Pain
Interventions: Low pressure pneumoperitoneum (8-10mmHg) with AirSeal device, Standard pressure pneumoperitoneum (13- 15 mmHg) with AirSeal device; Procedure
Lead sponsor: Riverside University Health System Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Moreno Valley, California

Conditions: Opiate-Related Disorders, Opiate Use Disorder, Opioid
Interventions: MedSMA℞T Mobile; Behavioral
Lead sponsor: Olufunmilola Abraham; Other
Eligibility: 12 Years and older
Enrollment: 244 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 3
States / cities: Rockford, Illinois • Madison, Wisconsin

Conditions: Amyotrophic Lateral Sclerosis (ALS), Emotional Distress
Interventions: Resilient Together ALS; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Participants With Advanced Solid Tumor Malignancies
Interventions: VBC106; Drug
Lead sponsor: VelaVigo Bio Inc; Industry
Eligibility: 18 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Houston, Texas • West Valley City, Utah • Fairfax, Virginia

Conditions: B-Cell ALL, ALL (Acute B-Lymphoblastic Leukemia), Philadelphia Chromosome-Negative Lymphoblastic Leukemia, CD19-positive B-cell Acute
Interventions: Invariant Natural Killer T Cell Therapy; Biological
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Acute Lymphoblastic Leukemia in Remission, Hodgkin Lymphoma in Remission, Non-Hodgkin Lymphoma in Remission, Cancer Survivorship
Interventions: Phentermine/Topiramate ER, Health Behavior and Lifestyle Counseling; Drug · Behavioral
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 12 Years to 24 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Migraine in Adults
Interventions: Static magnetic helmet; Device
Lead sponsor: Marco Loggia; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Kidney Transplant
Interventions: mHealth app plus personalized coaching, Social work support; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Acneiform Drug Eruption, Acneiform Eruptions
Interventions: Isotretinoin, Doxycycline, Blood specimen collection, Photographs of Rash, Questionnaires, Stool Specimen collection; Drug · Procedure · Other + 1 more
Lead sponsor: University of California, San Francisco; Other
Eligibility: 12 Years to 39 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Anterior Cruciate Ligament (ACL) Tear
Interventions: Not listed
Lead sponsor: Arthroresearch LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Spinal Cord Injuries, Lower Motor Neuron Disease
Interventions: Abbot Dorsal Root Ganglion Neurostimulator; Device
Lead sponsor: Peter J. Grahn, Ph.D.; Other
Eligibility: 18 Years to 70 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Grade 1 Endometrial Endometrioid Carcinoma, Endometrial Intraepithelial Neoplasia, Metabolic Comorbidities
Interventions: Tirzepatide; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Search by objective public record fields.

Examining Engagement Trends Among Participants in Peripheral Neuropathy Clinical Research

Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D

Accessible Remote Rehabilitation System for Real-Time Biomechanical Monitoring

Augmented Depression Therapy (ADepT) Case Series

Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer

A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity

Health Engagement & Access Through Learning, Training, and Health-coaching With People With Intellectual and/or Developmental Disabilities

Facilitating Transition to Recommended PTSD Treatment

Intermittent Fasting for Pancreatitis

Acute Stimulation and Modulation of Stereotyped High-Frequency Oscillations

Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial

Transmission-Blocking Vaccine Pvs230D1-EPA/Matrix-M in Healthy Malaria-Naive Adults Using a Plasmodium Vivax Controlled Human Malaria Infection and Transmission Model

Low Pressure Pneumoperitoneum Using AirSeal® for Reduction in Postoperative Shoulder Pain Following Robot Assisted Hiatal Hernia Repair

MedSMA℞T Mobile ED

Resiliency Intervention for Patients With ALS and Their Care-Partners

First-in-Human Trial of VBC106 in Participants With Advanced Solid Tumors

BLinatumomab and iNKT in Relapsed B-Cell ALL

Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma

The Effect of Static Magnetic Fields on Neuroinflammation in Migraine

Tailored mHealth Coaching and Social Resource Support in Kidney Transplantation

Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway

Measuring Knee Laxity and Pivot Shift in ACL-Deficient Patients

Dorsal Root Ganglion Stimulation After Lower Motor Neuron Damage

Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer